MedPath

Telemonitoring in Patients With Heart Failure

Not Applicable
Completed
Conditions
Heart Failure, Congestive
Interventions
Device: Telemonitoring in patients with heart failure
Device: Health Buddy system
Registration Number
NCT00502255
Lead Sponsor
Maastricht University Medical Center
Brief Summary

The purpose of this study is to investigate if telemonitoring results in a decrease in hospital admissions, with equal quality of care defined as mortality, quality of life and unplanned visits with caregivers. Telemonitoring is expected to be more cost-effective than usual care in patients with heart failure.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
382
Inclusion Criteria
  • Patients > 18 years
  • Patients with heart failure NYHA classification II-III-IV
  • Patient experienced a period of fluid retention
  • Patient is treated by a cardiologist
  • Patient is followed-up by a heart failure nurse
  • Adequate knowledge of the Dutch language
  • Patient has an active telephone connection, preferably analogue
  • Patient is mental competent
  • Patient has the disposal of a balance
Exclusion Criteria
  • Patients suffering from COPD, Gold classification 3 or 4
  • Patient is a dialysis patient
  • Patient has a visual restriction to read the dialogues on the Health Buddy
  • Patient is hard of hearing or deaf
  • Patient suffers from a lethal sickness with a prognosis < 1 year
  • Patient participates in another trial
  • Patient needs a hospital admission on short time, i.e., < 3 months
  • Patient used the Health Buddy in an earlier stage
  • Patient is an illiterate person.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
usual careTelemonitoring in patients with heart failurepatients receive care as usual
telemonitoringHealth Buddy systemHealth Buddy in patients home situation
Primary Outcome Measures
NameTimeMethod
To what extent will the amount of planned contacts decrease without an increase of unplanned contacts?one year
To what extent does the use of Health Buddy result in a decrease in hospital admissions?one year
To what extent is Health Buddy® more cost-effective than usual care?one year
Secondary Outcome Measures
NameTimeMethod
What is the effect of Health Buddy® in patients with heart failure in regard to drug consumption and therapy compliance and level of knowledge, and quality of life?one year
To what extent is it - based on patients' characteristics - possible to identify patient with benefits?one year

Trial Locations

Locations (3)

Atrium Medische Centrum

🇳🇱

Heerlen, Limburg, Netherlands

Orbis Medische en Zorgconcern

🇳🇱

Sittard, Limburg, Netherlands

Maastricht University Hospital

🇳🇱

Maastricht, Limburg, Netherlands

© Copyright 2025. All Rights Reserved by MedPath